News

MILPITAS, Calif. – February 15, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The BIOADAPTOR RCT is...

Small study of long COVID patients experienced symptom improvement following EECP therapy

February 11, 2022 — SIRONA is the world’s first and the largest head-to-head randomized, controlled trial (RCT) investigating the use of a sirolimus drug-coated balloon (DCB) (Magic Touch PTA – Concept Medical) vs a paclitaxel DCB (CE...

Cardiovascular care essential part of post-infection care

Patients with severe coronary artery calcium had more than a 21 times increased risk

"Currently, all pacemakers pace the heart metronomically, which means a very steady, even pace. But when you record heart rate in a healthy individual, you see it is constantly on the move," says Professor Julian Paton, a lead researcher and...

A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed in hospitals with a 30-day mortality rate less than 5%.

A team of Canadian researchers have discovered an unexplored molecular mechanism of caffeine that could lead to new therapies for lowering cholesterol.

Clinicians indicate both Holter and MCT usage expected to grow in 2022 despite their differences

The American College of Cardiology’s Cardiovascular Summit Virtual (CV Summit) will feature three days of live content on Feb. 17-19, 2022, providing opportunities for the entire CV team to learn from multi-dimensional education courses on CV...